美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

生物科技指数ETF-iShares Nasdaq

201.09

-3.1700-1.55%

成交量：39.44万

成交额：7,953.44万

市值：105.47亿

市盈率：31.86

高：203.91

开：203.76

低：200.78

收：204.26

52周最高：217.12

52周最低：149.09

股本：5,245.00万

流通股本：5,245.00万

量比：0.36

换手率：0.75%

股息：0.35

股息率：0.17%

每股收益(TTM):6.31

每股收益(LYR):35.34

净资产收益率：24.54%

总资产收益率：0.10%

市净率：1.30

市盈率(LYR):5.69

数据加载中...

总览公司新闻资讯公告

Piper Sandler上调安进目标价至457美元

美国研究综述-安进、Analog Devices、莫德纳

复宏汉霖盘中涨近8% 近期联手山德士出海至多10款生物类似药

福泰制药(VRTX)股票8月19日收盘上涨4.48%：释放什么信号？

TradingKey中文

吉利德科学(GILD)股票8月19日盘中上涨3.66%：背后推手曝光

TradingKey中文

安进(AMGN)股票8月19日盘中上涨3.19%：背后推手曝光

TradingKey中文

再生元制药旗下Pasatru获欧洲药品管理局审评，全球申报在即

再生元制药获FDA批准：Pasatru（Garetosmab-Grts）上市，治疗成人进行性骨化性纤维发育不良

异动解读｜生物科技指数ETF-iShares Nasdaq盘中上涨5.1%，MNC并购加速叠加多重利好共振

瑞穗上调安进目标价至352美元

骏利亨德森投资：专利到期倒逼药企扩张生物科技并购、IPO市场同步复苏

智通财经网

药代违规进入诊疗区域！湘雅二医院发药品“停用函”，艾力斯、赛诺菲、安进、康蒂尼四药企上“黑榜”

TScan Therapeutics披露：安进将终止与其研究合作及许可协议

吉利德科学(GILD)股票8月18日盘中上涨3.14%：背后推手曝光

TradingKey中文

argenx SE(ARGX)股票8月17日盘中上涨16.67%：关键驱动因素揭晓

TradingKey中文

EyePoint股价料将创下历史最大跌幅，因其一款实验性眼科药物未能达到后期临床试验目标

美股开盘 | 三大指数涨跌不一，闪迪涨超3%，Argenx SE涨近9%

老虎资讯综合

EyePoint公司治疗年龄相关性眼病的药物晚期临床试验失败，股价暴跌

美股异动 | Argenx(ARGX.US)盘前涨超10% 自身免疫性肌炎药物Vyvgart III期研究达主要终点

美股异动丨Argenx SE盘前大涨超7%，Efgartigimod治疗肌炎III期试验成功

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/IBB/news?page=8"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指数ETF-iShares Nasdaq","latestPrice":201.09,"timestamp":1791909661643,"preClose":204.26,"halted":0,"volume":394405,"delay":0,"changeRate":-0.015519436012924643,"floatShares":52450000,"shares":52450000,"eps":6.311863,"marketStatus":"交易中","change":-3.17,"latestTime":"10-13 12:41:02 EDT","open":203.755,"high":203.91,"low":200.78,"amount":79534379.2111,"amplitude":0.015324,"askPrice":201.18,"askSize":241,"bidPrice":201.13,"bidSize":110,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":204.26,"sharesOutstanding":49450000,"nav":206.296467,"aum":10840879340.85,"dividendRate":0.001727,"bidAskSpread":0.000349,"preHourTrading":{"tag":"盘前","latestPrice":203.8,"preClose":204.26,"latestTime":"09:29 EDT","volume":282,"amount":57569.273519999995,"timestamp":1791898199999,"change":-0.46,"changeRate":-0.002252,"amplitude":0.009889},"postHourTrading":{"tag":"盘后","latestPrice":204.26,"preClose":204.26,"latestTime":"19:47 EDT","volume":10034,"amount":2049515.9148,"timestamp":1791848828793,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.359301,"impliedVol":0.2322,"impliedVolPercentile":0.4143},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":52450000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":0.359301,"shares":52450000,"dividePrice":0.3472,"high":203.91,"amplitude":0.015324,"preClose":204.26,"low":200.78,"week52Low":149.0909,"pbRate":"1.30","psRate":"253.76","week52High":217.12,"institutionHeld":0,"latestPrice":201.09,"committee":-0.373219,"eps":6.311863,"divideRate":0.001727,"volume":394405,"delay":0,"ttmEps":6.311863,"open":203.755,"prevYearClose":168.77,"prevWeekClose":206.49,"prevMonthClose":210.53,"prevQuarterClose":210.53,"fiveDayClose":203.1,"twentyDayClose":202,"sixtyDayClose":186.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"},{"executeDate":"2018-06-26","recordDate":"2018-06-27","paymentDate":"2018-07-02","value":0.15606,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661250489","title":"Piper Sandler上调安进目标价至457美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250489","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250489?lang=zh_cn&edition=fundamental","pubTime":"2026-08-21 15:20","pubTimestamp":1787296801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4566","LU2242646821.SGD","IE00BFTCPJ56.SGD","BK4599","LU2242652126.USD","LU2468319806.SGD","SG9999001440.SGD","LU2112291526.USD","BIB","BBH","LU1023059063.AUD","BK4585","PBE","LU1983299246.USD","BK4139","PJP","AMGN","LU0889565916.HKD","LU1571399168.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD","TBXU","UUP","IBB","IE00B4R5TH58.HKD","IBBQ","BK4581","LU1061106388.HKD","LU0122379950.USD","LU0320765992.SGD","UDN","BK4533","BK4534","BK4588","LU0289739699.SGD","LU2089984988.USD","IE00BJJMRZ35.SGD","LU0868494617.USD","LU0058720904.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660043834","title":"美国研究综述-安进、Analog Devices、莫德纳","url":"https://stock-news.laohu8.com/highlight/detail?id=2660043834","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660043834?lang=zh_cn&edition=fundamental","pubTime":"2026-08-20 15:49","pubTimestamp":1787212153,"startTime":"0","endTime":"0","summary":"美国研究综述-安进、Analog Devices、莫德纳路透8月20日-周四，华尔街证券分析师上调了多家在美国上市公司的评级和目标股价，其中包括安进、模拟设备公司和莫德纳。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4S44H0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772923.USD","LU0444973449.USD","LU1074936037.SGD","LU0795875086.SGD","BK4561","LU2089283258.USD","VHT","LU0310800379.SGD","BK4568","CLOU","LU2125909916.SGD","LU0109394709.USD","LU2458330243.SGD","LU2322448791.USD","BK4566","LU0128525689.USD","LU2552382058.USD","AIPI","BK4183","LU2098885051.SGD","LU2272731865.HKD","LU0082616367.USD","LU1548497426.USD","BK4114","LU0061475181.USD","LU2517655374.HKD","LU0053666078.USD","LU2244417387.USD","LU0417517546.SGD","LU1064131342.USD","LU1150488135.SGD","LU2290526834.HKD","LU0029864427.USD","LU0109392836.USD","LU1941712264.USD","LU1235294995.USD","BK4551","IE00B5TLWC47.USD","BK4501","LU0256863902.USD","LU2355687059.USD","LU1150488218.USD","IE00BN8TJ469.HKD","RXL","LU1261432733.SGD","LU1934455277.USD","FDTX","LU1989764664.SGD","LU0057025933.USD","BIB","LU2272731782.SGD","BK4613","LU0077335932.USD","FXL","LU0266013472.USD","LU0154236417.USD","LU1720051108.HKD","SG9999014567.USD","LU2125154778.USD","AIS","SG9999001440.SGD","IE000WAW04H5.SGD","TRUH","LU0689626769.HKD","LU0889565916.HKD","LU0127658192.USD","LU2112291526.USD","LU0265550946.USD","LU2360108059.USD","LU1988902786.USD","IE00BGHQF631.EUR","TGT","LU0006306889.USD","IE0000B7K699.USD","LU2347655156.SGD","LU1267930490.SGD","LU2491049909.HKD","LU2264538146.SGD","LU1585245621.USD","LU0433182093.SGD","LU1691799644.USD","SGXZ57979304.SGD","LU2361045086.USD","LU0211328371.USD","LU2237443895.HKD","LU0289961442.SGD","LU1551013425.SGD","MRVU","IE00BVYPNW00.USD","LU0106261372.USD","LU1861215975.USD","BK4535","LU0708994859.HKD","LU0738911758.USD","SG9999014039.USD","LU1823568750.SGD","LU0950375773.USD","BK4588","MRNA","FTXL","HCA","LU2473716301.USD","LU0210528500.USD","CIBR","CRWC","IDNA","LU0985489474.SGD","LU1642822529.SGD","LU0859254822.USD","LU2506952170.USD","IXJ","IHF","LU1066051811.HKD","LU2250418816.HKD","LU2360032135.SGD","LU0203347892.USD","LU0444971666.USD","SG9999002224.SGD","LU1839511570.USD","SG9999015978.USD","LU2129689431.USD","LU1066051498.USD","GNOM","LU2125154935.USD","QQQA","PCTY","BK4185","BK4512","WCBR","FAI","ADI","LU2089985449.USD","BK4504","LU2023250504.SGD","LU1989772840.SGD","LU1201861249.SGD","ABBV","LU0314106906.USD","LU0985320562.USD","IE00B1BXHZ80.USD","BK4141","MVLL","IE00BZ9MQY76.HKD","SOXY","DTCR","IE00B19Z9P08.USD","IE0004445239.USD","IHE","LU2517655028.SGD","LU2360107168.USD","IE00B3PB1722.GBP","LU1169589451.USD","LU2023250843.SGD","LU0795875169.SGD","LU0823421333.USD","BK4596","WISE","LU1162221912.USD","LU0234570918.USD","LU1935043536.SGD","LU0395794307.EUR","LU1670710661.SGD","LU1551013342.USD","LU0719512351.SGD","LU2360107325.USD","SNOU","IE00BMPRXQ63.HKD","LU2404859667.USD","LU2322448957.HKD","LU0114720955.EUR","LU2298321311.HKD","LU2491050071.SGD","SG9999015358.SGD","SG9999014021.USD","BBH","SNOY","LU0823421416.USD","LU0256863811.USD","LU1244550577.SGD","LU2404859741.USD","BK4094","LU0820561909.HKD","LU0690374961.EUR","LU2237438978.USD","LU1066053197.SGD","MEDX","GTEK","LU1670711040.USD","SG9999001176.USD","SG9999000418.SGD","BK4534","LU1951200564.SGD","BK4597","LU0980610538.SGD","LU1989764748.USD","CLOD","LU1917777945.USD","LU0122379950.USD","LU2133065610.SGD","BK4097","LU2506951958.HKD","LU2275660780.HKD","LU1861219969.SGD","LU0198837287.USD","AMGN","LU0965508806.USD","LU1923623000.USD","LU1815336760.USD","IE00B4R5TH58.HKD","IGV","LU0158827948.USD","LU0689472784.USD","IE000MB6IJN5.SGD","BK4592","LU0314104364.USD","LU0553294199.USD","IE0004086264.USD","BK4503","LU2487616109.SGD","MRK","LOW","LU0070302665.USD","SG9999014013.SGD","BK4155","IE00B5949003.HKD","LU1496350171.SGD","IE00B894F039.SGD","IE00B775SV38.USD","LU1035773651.USD","LU1923622291.USD","LU2125909759.SGD","LU2360106780.USD","LU1978683503.SGD","PJP","LU1720051017.SGD","LU0965509101.SGD","LU0069063385.USD","LU0128525929.USD","LU0432979614.USD","LU2491050154.USD","WDAY","LU0130102774.USD","LU1712237335.SGD","LU2458330169.SGD","LU1066051225.USD","LU2041044095.USD","LU0302445910.USD","SG9999014005.SGD","AIFD","LU1852331112.SGD","LU1861214812.USD","IE00BJT1NW94.SGD","IBBQ","LU2543165471.USD","BK4130","BUG","FHLC","BILL","LU0320765489.SGD","LGHT","LU0957808578.USD","CRWD","LU0690374615.EUR","LU1670627923.USD","MRNX","LU1267930227.SGD","LU1267930573.SGD","XLV","LU0130517989.USD","LU0211327993.USD","LU2089984988.USD","LU0289739699.SGD","LU0068578508.USD","ARTY","DAT","SG9999014559.SGD","LU0949170772.SGD","LU0170899867.USD","LU0097036916.USD","LU2552382132.HKD","IE00BLSP4452.SGD","LU1951198990.SGD","PAWZ","LU2931357623.SGD","LU0058720904.USD","LU0823434740.USD","LU1778281490.HKD","LU1674673428.USD","LU1084165304.USD","LU0472753341.HKD","LU0477156953.USD","LU1929549753.HKD","LU1244550221.USD","LU1291159041.SGD","XDAT","LU2357627491.SGD","BK4505","LU1983299246.USD","LU2092937221.SGD","LU2125909247.SGD","SMHX","SNOW","LU2237443465.HKD","IE000SO60NU8.SGD","WDNA","LU0274383776.USD","LU1119994496.HKD","LU2506952097.USD","BK4548","LU1974910355.USD","SG9999003800.SGD","IE00B42XCP33.USD","LU0889565833.HKD","IE00BDGV0183.EUR","LU2237443622.USD","WOLF","SG9999015952.SGD","LU1670711123.USD","LU2517655291.USD","IE000F7OJYX1.SGD","LU0823417737.USD","XNTK","IE000BZT7R73.USD","EL","TJX","BK4116","LU1057294990.SGD","LU1989763005.USD","BK4607","IE00BBT3K403.USD","LU1093756168.USD","LU0823411888.USD","BK4543","SG9999015986.USD","FTXH","LU2125909593.SGD","LU1992135472.HKD","LU2237443549.SGD","LU0786609619.USD","BK4558","LU0320765646.SGD","LU2129689514.USD","BK4139","BK4604","LU1670628061.USD","LU0965509283.SGD","LU1804176565.USD","LU0289739343.SGD","LU0545039389.USD","LU0820561818.USD","IE00B19Z9Z06.USD","BK4528","LU2265009873.SGD","SG9999013999.USD","LU0211331839.USD","LU1674673691.USD","LU0320765992.SGD","IE00BZ199S13.USD","LU1316542783.SGD","LU0476273544.USD","LU2468319806.SGD","BK4007","LU1023059063.AUD","BK4083","LU0310800965.SGD","LU0868494708.USD","LU1169590202.USD","LU2106854487.HKD","04332","LU0310799852.SGD","LU1506573853.SGD","LU1430594728.SGD","LU1992135399.USD","IE00BLSP4239.USD","PPH","AGNG","LU0642271901.SGD","LU1116320901.HKD","LU2506951875.HKD","SG9999014542.SGD","BK4605","LU1941712348.USD","LU0511384066.AUD","TBXU","BK4515","BK4550","LU0661504455.SGD","LU1934455194.USD","IE00B3S45H60.SGD","LU0823434583.USD","LU0187121727.USD","LU2552382215.SGD","IE00BJJMRZ35.SGD","LU1923622614.USD","LU0265550359.USD","LU2242646821.SGD","MRVX","LU0965509010.AUD","LU0868494617.USD","LU1732800096.USD","LU2023251221.USD","LU0124676726.USD","LU1003077747.HKD","IE00B2B36J28.USD","LU1496350502.SGD","LU0124384867.USD","LU2298322129.HKD","BK4516","LU1699723380.USD","MRNY","BMED","LU0456855351.SGD","LU1116320737.USD","IE0002141913.USD","LU2433249047.HKD","LU0098860793.USD","LU0943347566.SGD","LU1303367103.USD","LU2087621335.USD","LU2357305700.SGD","LU1046421795.USD","LU1061106388.HKD","LU2129689605.HKD","LU1623119135.USD","IE00BMPRXN33.USD","LU0726765562.USD","LU1718418525.SGD","IE00B19Z3581.USD","CRWL","LU1571399168.USD","LU2324357040.USD","SG9999001176.SGD","IE00BFTCPJ56.SGD","MRVL","LU0882574055.USD","LU1934455863.HKD","IE00BZ1G4Q59.USD","LU0081259029.USD","LU1069347547.HKD","IE00BKVL7J92.USD","LU1803068979.SGD","BK4585","LU1093756325.SGD","LU2237443978.SGD","IBB","LU2211815571.USD","SG9999015945.SGD","BK4533","LU1861220033.SGD","HAKY","IE00BVYPNV92.GBP","IE0002270589.USD","LU1670710588.SGD","SG9999015341.SGD","SG9999011175.SGD","SPAM","WUGI","IE0034235188.USD","LU0238689110.USD","LU2272731600.USD","LU1989771016.USD","LU0823417653.USD","BK4554","IE000M9KFDE8.USD","BK4560","SG9999014575.USD","IE0004091025.USD","LU0208291251.USD","LU0648001328.SGD","LU0823416689.USD","IE0009355771.USD","GLAM","LU2089284900.SGD","IE00B19Z3B42.SGD","LU0861579265.USD","LU2461242641.AUD","LU0724618433.USD","GDOC","LU1037948541.HKD","IE00BSNM7G36.USD","LU2286300806.USD","IYH","LU0234572021.USD","LU1732799900.SGD","BK4598","LU0878866978.SGD","LU0942090050.USD","BK4532","IE00BMPRXR70.SGD","LU2237443382.USD","PBE","LU1244550494.USD","LU2361044949.HKD","LU1935042991.SGD","HRTS","LU2242652126.USD","PSWD","BK4559","IE0009356076.USD","IE00BD6J9T35.USD","JDOC","LU0094547139.USD","LU0912757837.SGD","LU0056508442.USD","LU0203345920.USD","LU0052756011.USD","LU2361044865.SGD","BK4599","LU2347655073.USD","LU1989773731.SGD","SG9999002232.USD","BK4023","LU1489326972.SGD","BK4581","LU0312595415.SGD","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660747701","title":"复宏汉霖盘中涨近8% 近期联手山德士出海至多10款生物类似药","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747701","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747701?lang=zh_cn&edition=fundamental","pubTime":"2026-08-20 10:56","pubTimestamp":1787194560,"startTime":"0","endTime":"0","summary":"模拟交易客户端复宏汉霖盘中涨近8%，截至发稿，股价上涨6.87%，现报70.05港元，成交额1646.58万港元。基于上述首批约定，山德士将向复宏汉霖支付首付款、相关里程碑付款及不可退还的选择权费共计至高3.22亿美元；2026年，复宏汉霖预计可达成的开票金额总计不超过1.005亿美元。值得一提的是，海外市场已成为复宏汉霖业绩增长的重要组成部分。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-20/doc-ininxqxw2099208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","XPH","LU2272731865.HKD","02696","PPH","HK0000306685.HKD","HK0000320223.HKD","LU2272731600.USD","LU2322448957.HKD","IBB","BK4585","LU2473716301.USD","HK0000320264.USD","BK4588","IE00B5TLWC47.USD","LU2322448791.USD","HK0000306701.USD","LU1992135472.HKD","LU1992135399.USD","LU2272731782.SGD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473644","title":"福泰制药(VRTX)股票8月19日收盘上涨4.48%：释放什么信号？","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473644","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473644?lang=zh_cn&edition=fundamental","pubTime":"2026-08-20 04:16","pubTimestamp":1787170582,"startTime":"0","endTime":"0","summary":"• 在竞争对手临床试验宣告失败后，福泰制药股价飙升至历史新高。\n• 第二季度营收超出预期，公司同时上调了全年业绩指引。\n• 分析师纷纷给出看涨评级，平均目标价达 563.25 美元。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262119125-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IBB","LU0823416689.USD","LU1778281490.HKD","BBH","LU1674673691.USD","BK4532","LU2456880835.USD","SGXZ57979304.SGD","LU2362541273.HKD","LU2417539215.USD","LU1585245621.USD","PBE","IE00BJT1NW94.SGD","LU0109394709.USD","GNMX","LU2462157665.USD","LU2236285917.USD","VRTX","SG9999001176.SGD","LU2468319806.SGD","LU2362541513.USD","TBXU","BK4588","BK4567","LU0058720904.USD","LU1093756325.SGD","LU0417517546.SGD","LU2324357040.USD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0234570918.USD","IE00B19Z9Z06.USD","IBBQ","IE0009355771.USD","LU0432979614.USD","IE00B19Z9P08.USD","LU0320765992.SGD","LU1069344957.HKD","LU1674673428.USD","IE00B4R5TH58.HKD","LU0079474960.USD","LU0256863811.USD","LU1035775433.USD","LU2237438978.USD","IDNA","BK4139","IE00B19Z3581.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660113478","title":"吉利德科学(GILD)股票8月19日盘中上涨3.66%：背后推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660113478","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660113478?lang=zh_cn&edition=fundamental","pubTime":"2026-08-20 03:17","pubTimestamp":1787167048,"startTime":"0","endTime":"0","summary":"• 得益于HIV产品组合增长加速，吉利德上调了全年销售指引。\n• 联邦法院颁布禁令阻止海外进口，以保护其核心市场份额。\n• 分析师给予“买入”评级，平均目标价为157.79美元。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118864-market-movers-gild-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455863.HKD","LU1839511570.USD","SG9999015952.SGD","LU1037948541.HKD","BK4139","IE00B19Z3581.USD","LU0320765992.SGD","LU1674673428.USD","BIB","IE00B7SZLL34.SGD","LU2468319806.SGD","LU1585245621.USD","IBB","LU2324357040.USD","BK4588","LU0058720904.USD","LU0289739699.SGD","LU1023059063.AUD","LU1674673691.USD","GILD","IE0002270589.USD","LU1057294990.SGD","BBH","BK4550","BK4578","MEDI","LU0823416689.USD","SG9999015986.USD","LU1934455194.USD","BK4583","LU1778281490.HKD","SG9999015945.SGD","IE00BSNM7G36.USD","SG9999015978.USD","LU0965509010.AUD","TBXU","LU0965509101.SGD","LU1934455277.USD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0965508806.USD","BK4568","LU1066051498.USD","IBBQ","TMED","BK4532","LU0234570918.USD","BMED","IE00B19Z3B42.SGD","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660819420","title":"安进(AMGN)股票8月19日盘中上涨3.19%：背后推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660819420","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660819420?lang=zh_cn&edition=fundamental","pubTime":"2026-08-20 02:16","pubTimestamp":1787163383,"startTime":"0","endTime":"0","summary":"• Argus上调安进目标价，并重申“买入”评级。\n• 第二季度财务业绩超出华尔街的营收和盈利预期。\n• 技术指标显示 MACD 买入信号及 RSI 买入条件。","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118749-market-movers-amgn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","IE00BJJMRZ35.SGD","LU0289739699.SGD","IE00B2B36J28.USD","BK4534","LU0868494617.USD","LU1023059063.AUD","LU2242652126.USD","BK4566","LU0109394709.USD","LU2112291526.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","AMGN","LU2242646821.SGD","IE0009355771.USD","PBE","TBXU","BK4581","BK4585","BK4139","LU1983299246.USD","BK4588","BK4599","BK4533","LU2089984988.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","IBB","BIB","LU0320765992.SGD","LU1571399168.USD","PJP","LU2468319806.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU0122379950.USD","IBBQ","IE0002141913.USD","LU1057294990.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105025052","title":"再生元制药旗下Pasatru获欧洲药品管理局审评，全球申报在即","url":"https://stock-news.laohu8.com/highlight/detail?id=1105025052","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105025052?lang=zh_cn&edition=fundamental","pubTime":"2026-08-20 02:00","pubTimestamp":1787162410,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布，其研发的药物Pasatru已被欧洲药品管理局纳入审评流程。与此同时，该公司正积极筹备在全球范围内提交该药物的上市申请。欧洲药品管理局的审评启动，为这款药物在欧洲地区的获批前景增添了重要砝码。业界分析认为，Pasatru若能顺利通过审评，有望为相关疾病领域带来新的治疗选择。再生元制药在创新药物研发领域深耕多年，此次针对Pasatru的全球布局，也彰显了其对这一候选药物商业潜力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1917777945.USD","LU2023250504.SGD","IBBQ","LU2237438978.USD","BK4588","LU2362541513.USD","LU2468319806.SGD","LU0823416689.USD","LU2362541273.HKD","REGN","BBH","LU0114720955.EUR","LU2362540622.SGD","BK4585","LU1974910355.USD","IBB","LU2106854487.HKD","LU0109394709.USD","LU0823434583.USD","LU0320765992.SGD","LU0289739699.SGD","LU2089984988.USD","BK4139","LU0882574055.USD","LU0053666078.USD","LU0058720904.USD","LU0823434740.USD","LU0889565916.HKD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188134905","title":"再生元制药获FDA批准：Pasatru（Garetosmab-Grts）上市，治疗成人进行性骨化性纤维发育不良","url":"https://stock-news.laohu8.com/highlight/detail?id=1188134905","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188134905?lang=zh_cn&edition=fundamental","pubTime":"2026-08-20 01:59","pubTimestamp":1787162353,"startTime":"0","endTime":"0","summary":"再生元制药公司今日宣布，其研发的新药Pasatru已获得美国食品药品监督管理局的正式批准，用于治疗成人进行性骨化性纤维发育不良。这一罕见疾病此前一直缺乏有效的治疗手段，此次获批为患者带来了新的希望。FDA的此次批准基于多项临床研究数据，结果显示Pasatru在减缓异位骨化进展方面表现出显著疗效，且安全性可控。未来，再生元制药计划进一步拓展Pasatru的适应症范围，并探索其在其他相关疾病中的潜在应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","IBB","LU2362540622.SGD","LU0109394709.USD","LU0053666078.USD","LU0320765992.SGD","REGN","LU2362541513.USD","LU1917777945.USD","LU2237438978.USD","TBXU","LU0889565916.HKD","LU2023250504.SGD","LU2468319806.SGD","BK4585","LU2106854487.HKD","BK4139","LU0882574055.USD","LU0823434740.USD","LU1974910355.USD","LU0058720904.USD","LU0114720955.EUR","BBH","BK4588","LU0823434583.USD","LU0289739699.SGD","LU2089984988.USD","IBBQ","LU2362541273.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187101531","title":"异动解读｜生物科技指数ETF-iShares Nasdaq盘中上涨5.1%，MNC并购加速叠加多重利好共振","url":"https://stock-news.laohu8.com/highlight/detail?id=1187101531","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187101531?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 22:09","pubTimestamp":1787148587,"startTime":"0","endTime":"0","summary":"8月19日，生物科技指数ETF-iShares Nasdaq盘中上涨5.1%，报213.88美元，成交额1.03亿美元。消息面上，生物科技板块近期迎来多重利好共振。另一方面，AI制药订单持续落地驱动生命科学上游需求攀升，板块整体景气度回暖。此外，再生元Libtayo获加拿大卫生部批准用于高危皮肤鳞状细胞癌辅助治疗，进一步提振市场情绪。该ETF追踪纳斯达克生物医疗指数，包含在纳斯达克上市的生物医疗公司，成分和权重可能随时间变化。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660585446","title":"瑞穗上调安进目标价至352美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660585446","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660585446?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 16:55","pubTimestamp":1787129710,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4139","IE00B2B36J28.USD","LU0889565916.HKD","LU0289739699.SGD","LU0868494617.USD","LU2112291526.USD","UUP","AMGN","LU1571399168.USD","BBH","BK4588","LU0109394709.USD","LU2242646821.SGD","LU2242652126.USD","LU2468319806.SGD","LU1023059063.AUD","UDN","BK4585","LU0122379950.USD","LU1983299246.USD","IBB","PJP","BIB","BK4533","TBXU","IBBQ","LU1057294990.SGD","BK4581","IE0009355771.USD","IE0002141913.USD","LU0058720904.USD","LU1061106388.HKD","LU0320765992.SGD","SG9999001440.SGD","IE00BJT1NW94.SGD","BK4534","LU2089984988.USD","PBE","IE00BJJMRZ35.SGD","BK4566","BK4599","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431564","title":"骏利亨德森投资：专利到期倒逼药企扩张 生物科技并购、IPO市场同步复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431564","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431564?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 16:06","pubTimestamp":1787126785,"startTime":"0","endTime":"0","summary":"骏利亨德森投资称，尽管利率较市场年初的预期为高，但生物科技行业交易活动的增长动力持续不减。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["IBBJ","IBB","IJT","PBE","BIS","BK4582","IYG","IAI","GTPE","JDOC","BBP","MRNY","BK4585","IWO","BBC","MRNX","FBT","QSML","BIB","BK4588","SPCK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660416851","title":"药代违规进入诊疗区域！湘雅二医院发药品“停用函”，艾力斯、赛诺菲、安进、康蒂尼四药企上“黑榜”","url":"https://stock-news.laohu8.com/highlight/detail?id=2660416851","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660416851?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 09:48","pubTimestamp":1787104101,"startTime":"0","endTime":"0","summary":"湘雅二医院方面向澎湃新闻表示，院方确有发该“协办函”。据此次公布的协办函，对几家涉事药企的处理决定颇为严厉。近年来，医药代表违规已不仅是行业道德问题，而是监管重点。此次湘雅二医院将企业列入购销负面清单，正是医院端落地上述政策的缩影。湘雅二医院相关负责人表示，自国家在2020年底建立医药代表备案制度，医院就积极响应国家政策，并不断完善内部制度和执行流程。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787103396417327872","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LU2468319806.SGD","BK0239","IBBQ","IE0009355771.USD","LU1023059063.AUD","688578","BK4566","LU2242646821.SGD","PBE","IE00BJT1NW94.SGD","IBB","LU1061106388.HKD","SG9999001440.SGD","IE00BJJMRZ35.SGD","BK4533","LU0109394709.USD","BK4585","BK4139","LU1571399168.USD","BK4534","LU2089984988.USD","LU1057294990.SGD","LU0868494617.USD","LU0320765992.SGD","LU0058720904.USD","BK4581","BK4599","LU0889565916.HKD","IE00B2B36J28.USD","LU1983299246.USD","LU2112291526.USD","LU2242652126.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","PJP","IE00B4R5TH58.HKD","BK4588","LU0289739699.SGD","TBXU","BIB","BBH","AMGN","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192416297","title":"TScan Therapeutics披露：安进将终止与其研究合作及许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1192416297","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192416297?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 05:04","pubTimestamp":1787087050,"startTime":"0","endTime":"0","summary":"值得注意的是，安进作为全球领先的生物制药公司，此举无疑将对TScan Therapeutics的研发管线及未来战略布局产生深远影响。TScan Therapeutics方面表示，将仔细评估这一变化对公司在研项目及整体运营带来的潜在影响。对于TScan Therapeutics而言，此番变故或许意味着需要重新校准其研发路径，并探索新的合作机会或资金来源以继续推进其创新疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU0868494617.USD","TBXU","LU0889565916.HKD","IE0002141913.USD","PBE","LU0320765992.SGD","IE00BJT1NW94.SGD","BK4533","BK4599","BBH","SG9999001440.SGD","LU0109394709.USD","BK4566","LU1983299246.USD","IE00B2B36J28.USD","LU2242646821.SGD","AMGN","LU1057294990.SGD","LU0058720904.USD","BK4581","IBB","BK4534","BK4585","LU2089984988.USD","LU2468319806.SGD","BIB","IE00BJJMRZ35.SGD","BK4588","PJP","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU1571399168.USD","BK4139","IE00B4R5TH58.HKD","LU0122379950.USD","LU2242652126.USD","LU1061106388.HKD","LU2112291526.USD","BK4539","TCRX","IE0009355771.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660491619","title":"吉利德科学(GILD)股票8月18日盘中上涨3.14%：背后推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660491619","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660491619?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 02:16","pubTimestamp":1787076999,"startTime":"0","endTime":"0","summary":"• 联邦法院禁令阻止了吉利德关键HIV药物的海外进口。\n• 强劲的基础业务营收增长与上调业绩指引提振了市场乐观情绪。\n• 肿瘤领域的战略投资及机构看涨期权活动的活跃支撑了股价的上涨势头。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262115765-market-movers-gild-20260818","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455863.HKD","LU2089984988.USD","LU0114720955.EUR","LU1839511570.USD","SG9999015952.SGD","LU1037948541.HKD","IE00B19Z3581.USD","LU0320765992.SGD","LU1674673428.USD","BIB","IE00B7SZLL34.SGD","LU1585245621.USD","IBB","LU2324357040.USD","LU0058720904.USD","LU0289739699.SGD","LU1023059063.AUD","LU1674673691.USD","LU1061106388.HKD","LU1571399168.USD","LU1066053197.SGD","GILD","BK4566","BBH","BK4550","BK4578","LU1430594728.SGD","LU0823416689.USD","LU2112291526.USD","BK4585","MEDI","LU1037948897.HKD","BK4583","SG9999015986.USD","LU1778281490.HKD","LU0109394709.USD","IE00BSNM7G36.USD","SG9999015978.USD","TBXU","IE00B3T34201.USD","LU0965509101.SGD","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","LU0965508806.USD","IBBQ","TMED","LU2087621335.USD","BK4532","BMED","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660439442","title":"argenx SE(ARGX)股票8月17日盘中上涨16.67%：关键驱动因素揭晓","url":"https://stock-news.laohu8.com/highlight/detail?id=2660439442","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660439442?lang=zh_cn&edition=fundamental","pubTime":"2026-08-18 00:16","pubTimestamp":1786983373,"startTime":"0","endTime":"0","summary":"• Argenx 宣布其药物 VYVGART Hytrulo 在治疗肌炎的 3 期 ALKIVIA 研究中取得积极结果。\n• 该公司公布全年营收为 41.5 亿美元，净利润为 12.9 亿美元。\n• 分析师给予“买入”评级，平均目标价为 1083.77 美元。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262112725-market-movers-argx-20260817","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4588","BK4139","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0109394709.USD","LU0823416689.USD","IE0034235188.USD","BK4585","IE00BJT1NW94.SGD","TBXU","BK4505","LU0320765992.SGD","ARGX","IE0009355771.USD","LU0889565916.HKD","IBB","IE0002141913.USD","IE00BFTCPJ56.SGD","FMED","IE00BJJMRZ35.SGD","LU1983260115.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660332334","title":"EyePoint股价料将创下历史最大跌幅，因其一款实验性眼科药物未能达到后期临床试验目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2660332334","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660332334?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 22:15","pubTimestamp":1786976114,"startTime":"0","endTime":"0","summary":"BUZZ-EyePoint股价料将创下历史最大跌幅，因其一款实验性眼科药物未能达到后期临床试验目标最新动态8月17日-**EyePoint公司（EYPT.O）股价暴跌71%至4.17美元，有望创下有史以来最大单日跌幅，并跌至2025年4月以来的最低点**这家药物开发商表示，其实验性眼科药物Duravyu在针对湿性年龄相关性黄斑变性（视力丧失的主要原因之一）患者开展的晚期临床试验中，未能达到主要目标","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4T44E101:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU1917777945.USD","LU1974910355.USD","LU0109394709.USD","IBB","BBH","LU2023250504.SGD","BK4588","LU0823434583.USD","LU0114720955.EUR","REGN","LU0823416689.USD","LU0053666078.USD","LU0289739699.SGD","LU2468319806.SGD","LU2362540622.SGD","BK4585","LU2362541513.USD","LU0823434740.USD","LU2106854487.HKD","IBBQ","LU2089984988.USD","BK4007","TBXU","LU2362541273.HKD","LU0058720904.USD","LU0889565916.HKD","EYPT","BK4139","LU2237438978.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137019504","title":"美股开盘 | 三大指数涨跌不一，闪迪涨超3%，Argenx SE涨近9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1137019504","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137019504?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 21:32","pubTimestamp":1786973544,"startTime":"0","endTime":"0","summary":"8月17日，美股三大指数开盘涨跌不一，道琼斯指数跌0.23%，标普500指数涨0.04%，纳斯达克综合指数涨0.24%。美股存储股普涨，SK海力士、西部数据、闪迪涨超3%，美光科技、希捷科技涨超2%。OmniAb涨超23%，公司此前宣布与礼来达成3.7亿美元药物研发协议。Argenx SE涨近9%，Efgartigimod治疗肌炎III期试验成功。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0127658192.USD","SKDD","SG9999018857.SGD","LU0823434583.USD","BK4585","XLK","LU2048586759.USD","BK4588","ELIS","LU0274383776.USD","LU2102340556.USD","FDTX","DIA","LU0889565916.HKD","COWG","LU0466842654.USD","LU1720051017.SGD","CHPS","JDOC","LU0225283273.USD","LU2168563687.JPY","SPYQ",".SPX","SKHU","AGNG","BK4170","LU2237443622.USD","LU0109394709.USD","LU2168564222.USD","IE00BKDWB100.SGD","SG9999017495.SGD","CURE","IE00BFSS8Q28.SGD","IE00B19Z9P08.USD","LU0957808578.USD","XLV","LU0133085943.USD","IE0004445015.USD","LU0672654240.SGD","UDOW","LU2286300806.USD","RXL","LU0082616367.USD","LU0345770308.USD","LU2250418816.HKD","LU2168564065.EUR","LU2750360641.GBP","IE00B894F039.SGD","LU0943347566.SGD","LU0471298694.HKD","BK4139","MIC","LU2491050071.SGD","LU0320765992.SGD","LU0162691827.USD","LU2237443549.SGD","LU1720051108.HKD","FTXL","LU0708995401.HKD","LU0158827781.USD","SMU00main","LU1674673428.USD","IE00B7SZLL34.SGD","LU2417539215.USD","JGRO","IE000M9KFDE8.USD","SG9999015986.USD","LU1623119135.USD","DDM","LU1064131342.USD","IVV","LU2462157665.USD","LU1235294995.USD","LU0114720955.EUR","LU1778281490.HKD","IE00BWXC8680.SGD","IE0034235303.USD","SKHX","LU1670628061.USD","LU1823568750.SGD","LU0256863902.USD","LU2237443382.USD","SG9999014898.SGD","LU0122379950.USD","LU1127390331.HKD","LU1093756168.USD","LU1642822529.SGD","AIFD","BK4533","BK4007","IE00B5949003.HKD","LU0097036916.USD","LU1804176565.USD","VGT","BK4543","FSMD","MU","IE00BKPKM429.USD","LU2756315318.SGD","FCUS","LU1629891620.HKD","LU1803068979.SGD","LU1670627923.USD","LU2552382058.USD","LU2552382132.HKD","LU2458330243.SGD","SNXX","WDC","LU2357305700.SGD","LU1917777945.USD",".IXIC","LLII","LU1868837300.USD","LU1145028129.USD","IE0001KFT4U8.USD","LU0072461881.USD","CNEQ","LU0354030511.USD","LU1868836914.USD","SG9999014914.USD","LU0061475181.USD","BK4532","LU2361044865.SGD","LU0203202063.USD","LU0320765059.SGD","YMmain","LU2054465674.USD","LU2491050154.USD","SG9999018865.SGD","YSPY","IE0002141913.USD","IXN","IXJ","LU2111349929.HKD","LU2456880835.USD","LU1814569148.SGD","LU2106854487.HKD","LU1366192091.USD","LU0889565833.HKD","LU0471298777.SGD","VHT","SNDU","LU0056508442.USD","MHIP","SPYM","LU1974910355.USD","LU0096364046.USD","LU0786609619.USD","LU0203347892.USD","PSI","LU0787776722.HKD","LU0058720904.USD","LLYZ","LU0174119429.USD","LU2265009873.SGD","LU2471134952.CNY","LU1983260115.SGD","LU0882574055.USD","SCHA","AIQ","TRFK","HRTS","UPRO","IE0004445239.USD","SGXZ81514606.USD","SG9999014906.USD","LU0820561818.USD","ARGX","LU0456855351.SGD","LU0006061336.USD","RULE","LU1914381329.SGD","IE00BSNM7G36.USD","LU2471134523.USD","LU2756315664.SGD","LU1323610961.USD","LU0234572021.USD","LU2361044949.HKD","LU0006306889.USD","SPDN","LU1232071149.USD","LU2896262040.SGD","LU2023250330.USD","LU0964807845.USD","MEDX","SPUU","QQQA","SMH","LEGR","LU0889566641.SGD","LU0106261372.USD","SG9999001176.SGD","TRUH","SGXZ99366536.SGD","SNDK","OPTZ","LU1551013425.SGD","CANC","SPXU","LU0640476718.USD","BK4527","STX","SG9999001424.SGD","IE00BJT1NW94.SGD","SGXZ31699556.SGD","WDNA","LU2112291526.USD","LU2213496289.HKD","LU2028103732.USD","LU2271345857.HKD","LU0316494557.USD","LU2087625088.SGD","SG9999015945.SGD","LU1291159041.SGD","BK4516","LU0432979614.USD","DXD","IE00BJLML261.HKD","SSO","LU1035775433.USD","THNR","BK4575","LU2237443895.HKD","SNDQ","MUD","IE00B4R5TH58.HKD","DRMY","LU2264538146.SGD","MUZ","SG9999015952.SGD","LU1979441026.SGD","LU2089985449.USD","IE00B775H168.HKD","LU0792757196.USD","IE00B19Z9Z06.USD","LU2468319806.SGD","LU2403377893.USD","SKUU","EGGY","IE00BJJMRZ35.SGD","LU1366333091.USD","LU0823434740.USD","OZEM","LU2458330169.SGD","SGXZ51526630.SGD","LU0079474960.USD","LU1316542783.SGD","IE00BJJMRX11.SGD","CNAV","LU1712237335.SGD","WDCX","LU2023250504.SGD","BK4599","LU1989764748.USD","IE0009355771.USD","LU0094547139.USD","TTXU","LU1868837136.USD","LU0683600562.USD","SGXZ57979304.SGD","LU0719512351.SGD","LU0963586101.USD","LU0476273544.USD","FTEC","IE00BJJMRY28.SGD","LU0642271901.SGD","AIS","LU2290526834.HKD","SKHZ","LU0256863811.USD","SNDC","LU2063271972.USD","SG9999001176.USD","CHAT","CGGO","TMSL","BK4512","LU0203201768.USD","LU1069344957.HKD","BK4554","LU0882574139.USD","BK4534","LU1057294990.SGD","LU0240878834.USD",".DJI","DMAX","SPYU","LU2357627491.SGD","LU2746668461.USD","LU0354030438.USD","LU1852331112.SGD","LU0157215616.USD","LU0444973449.USD","IE00BFTCPJ56.SGD","LU2236285917.USD","PTF","IHE","LU2931357623.SGD","SDOW","LU0417517546.SGD","07709","ILDR","FMED","LU0345770993.USD","LU0820562030.AUD","LU0154236417.USD","LU2491049909.HKD","LU1861215975.USD","LU0109391861.USD","LU2361045086.USD","LU2750360997.AUD","LU2211815571.USD","SKHA","SG9999015978.USD","LU1069347547.HKD","MULL","DISK","MUYY","LU1674673691.USD","LLY","LU1815336760.USD","LU2023251221.USD","LU2602419157.SGD","SPYH","LU1861220033.SGD","ARTY","SOXQ","LU2237438978.USD","LU0289739699.SGD","IE00B1BXHZ80.USD","CHPX","LU0081259029.USD","LU0689472784.USD","IE0002270589.USD","BAI","ELIL","LU0820561909.HKD","QQQG","SKHYV","LU1989771016.USD","SMAX","IE00B19Z3B42.SGD","LU1267930813.SGD","IE00B7KXQ091.USD","LU0240877869.USD","SOXX","LU2108987350.USD","GDOC","LU0444971666.USD","LU2471134879.HKD","LU2746668974.SGD","IBB","LU1023059063.AUD","SG9999013999.USD","SH","HBMX","LU2089284900.SGD","LU1046421795.USD","LU1061106388.HKD","LU1989764664.SGD","WUGI","PPH","BOBP","LU0859254822.USD","LU2168564495.EUR","LU2462591350.SGD","BK4566","SKHY","FHLC","LU2471134796.USD","IE0005OL40V9.USD","LU2552382215.SGD","MUU","BK4553","EMSF","SPXS","USXF","BK4581","LU1868836591.USD","SPY","LU2168564149.EUR","SCHM","LU2360106947.USD","BK4579","DOG","TMED","SK","LU2324357040.USD","LU0109392836.USD","LU0823416689.USD","LU1035773651.USD","LU0203345920.USD","LU0353189680.USD","IE00B1XK9C88.USD","BK4505","PJP","LU2543165471.USD","SG9999014880.SGD","LU0266013472.USD","LU1551013342.USD","GB00BDT5M118.USD","LU2461242641.AUD","VOO","IE00BFSS7M15.SGD","LU0198837287.USD","IE0009356076.USD","MMAX","LU0353189763.USD","LU1868836757.USD","LU2089984988.USD","BK7142","SNDG","LU2360106780.USD","LU0385154629.USD","LU1267930730.SGD","HYNX","WLDR","IE00BK4W5M84.HKD","LU2237443978.SGD","FXL","LU0238689110.USD","IYH","BK4141","EFIV","IE00B2B36J28.USD","FTXH","LU1280957306.USD","BK4605","IE00B4JS1V06.HKD","LU1548497426.USD","LU0210536198.USD","SHOC","SDS","HIBL","IE00BK4W5L77.USD","TBXU","IETC","LU0054578231.USD","IE00BN29S564.USD","MEDI","LU0158827948.USD","IE00B19Z3581.USD","STX.AU","IE0034235188.USD","LLYX","XNTK","LU2360107168.USD","LU2237443465.HKD","LU1988902786.USD","LU1983299246.USD","LU1093756325.SGD","SPXL","FAI","LU2089283258.USD","LU0323591593.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660848445","title":"EyePoint公司治疗年龄相关性眼病的药物晚期临床试验失败，股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2660848445","media":"路透中文","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660848445?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 19:14","pubTimestamp":1786965255,"startTime":"0","endTime":"0","summary":"EyePoint公司未能证明Duravyu在保护视力方面不比Eylea明显逊色。而在接受Eylea治疗的患者中，未出现此类情况。EyePoint的股价在早盘交易中跌至4.16美元。EyePoint计划于2027年上半年向美国FDA提交批准申请，具体取决于预计于今年晚些时候公布的第二项晚期临床试验结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4T44E0O1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU0320765992.SGD","LU2106854487.HKD","LU2362540622.SGD","BK4007","LU0889565916.HKD","BK4585","LU0114720955.EUR","LU1974910355.USD","LU2362541513.USD","REGN","LU2023250504.SGD","LU0058720904.USD","LU0823416689.USD","LU2362541273.HKD","IBB","LU0053666078.USD","LU0109394709.USD","IBBQ","EYPT","BK4588","LU0289739699.SGD","OTLK","LU0882574055.USD","LU2089984988.USD","LU0823434583.USD","LU2468319806.SGD","TBXU","LU0823434740.USD","LU1917777945.USD","LU2237438978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660481020","title":"美股异动 | Argenx(ARGX.US)盘前涨超10% 自身免疫性肌炎药物Vyvgart III期研究达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2660481020","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660481020?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 18:48","pubTimestamp":1786963699,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4134","IE0002141913.USD","IBB","LU0823416689.USD","IE00BJJMRZ35.SGD","FMED","IE0034235188.USD","III","LU1983260115.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","IE00B2B36J28.USD","TBXU","BK4588","ARGX","LU2324357040.USD","IE0009355771.USD","LU0889565916.HKD","LU0320765992.SGD","BK4505","IE00B4R5TH58.HKD","BK4585","BK4139","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660848605","title":"美股异动丨Argenx SE盘前大涨超7%，Efgartigimod治疗肌炎III期试验成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2660848605","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660848605?lang=zh_cn&edition=fundamental","pubTime":"2026-08-17 17:37","pubTimestamp":1786959424,"startTime":"0","endTime":"0","summary":"Argenx SE(ARGX.US)盘前涨超7%，报913.38美元。消息面上，公司宣布，Efgartigimod在治疗自身免疫性肌炎的III期ALKIVIA试验中达到了主要终点。在52周时，与安慰剂相比，药物在总改善评分(TIS) 上实现了具有统计学和临床意义的改善。此次试验成功对Argenx意义重大，开辟新市场：自身免疫性肌炎在美国影响约10万人，其中IMNM约2万，DM约4万，这是一个尚未被满足的巨大医疗市场。公司计划为IMNM提交加速审批申请，并将与FDA讨论DM的申报可能性。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202608/17/20260817706794.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202608/17/20260817706794.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260817/32337291.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IBB","IE0009355771.USD","LU0889565916.HKD","III","BK4139","IE00BFTCPJ56.SGD","LU2324357040.USD","BK4505","TBXU","IE0034235188.USD","FMED","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0823416689.USD","BK4588","IE00BJT1NW94.SGD","LU0109394709.USD","LU1983260115.SGD","BK4585","BK4134","IE00B2B36J28.USD","IE00B4R5TH58.HKD","ARGX","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}